# Molecular Partners AG: Form 20-F for the period ended Dec 31, 2022

- Company: [Molecular Partners AG](/companies/moln.md) (CIK 1745114)
- Form: 20-F
- Filed: 2023-03-09
- Accepted by EDGAR: Mar 9, 2023, 16:01 ET
- Period: 2022-12-31
- Accession: 0001745114-23-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745114/000174511423000003/moln-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745114/000174511423000003/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | CHF 189.6m | ifrs-full:Revenue |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | CHF 116.6m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | CHF 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | CHF 117.9m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | CHF 3.54 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | CHF 3.63 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | CHF 118.6m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | CHF 1.2m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2022-12-31 | CHF 87.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2022-12-31 | CHF 254.8m | ifrs-full:CurrentAssets |
| Total assets | at 2022-12-31 | CHF 262.3m | ifrs-full:Assets |
| Current liabilities | at 2022-12-31 | CHF 17.3m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2022-12-31 | CHF 27.1m | ifrs-full:Liabilities |
| Shareholders' equity | at 2022-12-31 | CHF 235.2m | ifrs-full:Equity |
| Shares outstanding | at 2022-12-31 | 36,044,706 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745114/000174511423000003/moln-20221231.htm

Filed Mar 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001745114-23-000003. Last ingested by Listed: Oct 29, 2026, 06:05 ET. No prices; not investment advice.
